At Dripology, B12 is offered as either an intramuscular injection or as part of an IV bag (either added to a Myers Cocktail or as a B12 push within a hydration drip)
It was originally studied for gastrointestinal healing but researchers quickly identified potent effects on connective tissue, tendons, ligaments, and joints
They target the same outcome (tissue repair) through different mechanisms : BPC-157: local growth factor expression, fibroblast stimulation, angiogenesis at the injury site TB-500: systemic cell migration, actin regulation, reduction of chronic inflammation throughout the body Standard Wolverine stack: BPC-157: 250500 mcg SC twice daily , injected near the injury site where possible TB-500: 22.5 mg SC twice weekly loading (weeks 14), then 2 mg weekly maintenance (weeks 512) CRITICAL: do not mix in the same vial - they can be injected in the same session but must remain in separate solutions
For NMB, it is the subtype-1 receptor, and for GRP-27, it is the subtype-2 receptor [195,196,197]
I believe the multi-tissue healing capacity of BPC-157 represents its greatest advantage for rib injuries specifically
Early studies suggest antioxidant properties and matrix turnover mechanisms that may be relevant in acute injuries and chronic overuse conditions
/assets/images/provider/photos/2736093.png)
